Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVS save search
US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.56%
H: 0.51%
C: 0.51%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.45%
H: 0.75%
C: 0.46%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 1.83%
H: 0.04%
C: -1.13%
kidney cancer novartis diagnostics therapeutics market
Low-Density Lipoprotein Test Global Market Report 2023, By Product Type (LDL-C; LDL-P; LDL-B) , By Component, By Disease Type, By Distribution Channel and By End User
Published: 2023-12-11 (Crawled : 17:00) - prnewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.02%
H: 0.9%
C: 0.77%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.75%
H: 0.55%
C: 0.27%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: 0.27%
H: 1.66%
C: 1.5%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.02%
H: 0.9%
C: 0.77%
disease report test distribution global market
Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma
Published: 2023-12-11 (Crawled : 13:00) - globenewswire.com
ERAS | $1.79 0.0% 570K
|
|
| O: 1.07%
H: 0.0%
C: -2.65%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.75%
H: 0.55%
C: 0.27%
fda melanoma granted designation advanced
Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
Published: 2023-12-11 (Crawled : 07:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.75%
H: 0.55%
C: 0.27%
novartis study
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.75%
H: 0.55%
C: 0.27%
fabhalta novartis trial results
S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2023 Review Results
Published: 2023-12-08 (Crawled : 23:00) - prnewswire.com
TCEHY | $38.94 0.04% 3.8M
|
Information
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
TCTZF | $38.63 2.11% 6.6K
|
Technology Services
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
| Email alert
Add to watchlist
DNOW | $14.65 -0.54% 0.0% 670K
|
Distribution Services
| Email alert
Add to watchlist
jones review results
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - December 8, 2023
Published: 2023-12-08 (Crawled : 16:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
kisqali breast risk novartis
Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -20.0%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PPCB | $0.001 -41.86% 11M
|
Manufacturing
|
| O: 0.0%
H: 2.61%
C: -4.35%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
active market
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Published: 2023-12-08 (Crawled : 14:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
kisqali breast risk novartis
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -2.79%
H: 0.62%
C: 0.62%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -2.2%
H: 0.0%
C: -0.27%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.5%
C: 0.5%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.42%
H: 0.67%
C: 0.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.2%
H: 0.55%
C: 0.1%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.08%
H: 1.45%
C: 1.17%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
reach market
FDA Approves Bio-Thera Solutions' Avzivi® (bevacizumab-tnjn), a biosimilar referencing Avastin®
Published: 2023-12-07 (Crawled : 00:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.97%
H: 0.3%
C: -0.19%
avzivi fda biosimilar
Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published: 2023-12-07 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.97%
H: 0.3%
C: -0.19%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.51%
H: 1.22%
C: 1.09%
IMNM | $15.5 -9.78% -10.84% 2.1M
|
Health Technology
|
| O: -0.64%
H: 1.67%
C: -1.16%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.67%
H: 0.91%
C: 0.57%
antibody therapeutics market
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: 0.05%
H: 5.74%
C: 3.18%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.42%
H: 2.37%
C: 1.45%
disease parkinson's revenue research therapeutics market
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
Published: 2023-12-06 (Crawled : 00:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
fabhalta fda first approval offering novartis
Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.51%
H: 0.13%
C: -1.68%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.14%
H: 0.78%
C: 0.22%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.73%
H: 0.06%
C: -1.38%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.2%
H: 0.2%
C: -0.76%
GOOGL | News S | $154.08 -1.24% -1.25% 32M
|
Technology Services
|
| O: 1.97%
H: 0.0%
C: 0.0%
GOOG | News S | $155.7 -1.12% -1.13% 20M
|
Technology Services
|
| O: 1.97%
H: 0.0%
C: 0.0%
ADBE | News A | $465.03 -1.72% -1.75% 3M
|
Technology Services
|
| O: 0.97%
H: 0.08%
C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market
Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.6%
H: 1.1%
C: -1.18%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.27%
H: 0.12%
C: 0.12%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.0%
H: 0.5%
C: 0.17%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.86%
H: 0.34%
C: -0.19%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.01%
H: 0.39%
C: 0.19%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.51%
H: 0.68%
C: 0.32%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
GLMD | $0.3787 -0.41% 18K
|
Health Technology
|
| O: 0.03%
H: 2.44%
C: -1.03%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -0.37%
america market
Smart Inhaler Technology Market size to grow by USD 46.37 million from 2022-2027, North America to account for 37% of market growth - Technavio
Published: 2023-12-01 (Crawled : 00:20) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
RMD | $178.85 0.7% 0.0% 1.2M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
IFNNF | News | $33.53 -2.1% 980
|
Electronic Technology
| Email alert
Add to watchlist
IFNNY | News | $32.57 -2.12% 140K
|
Manufacturing
| Email alert
Add to watchlist
america smart technology growth market
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published: 2023-12-01 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
| Email alert
Add to watchlist
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
| Email alert
Add to watchlist
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
disease companies health therapeutics market
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: 3.87%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -3.37%
H: 4.51%
C: 4.51%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.25%
H: 0.68%
C: 0.48%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: 0.0%
H: 38.05%
C: 23.01%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.06%
H: 0.35%
C: 0.29%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: 0.92%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -5.76%
H: 16.36%
C: 15.07%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -2.43%
H: 0.0%
C: 0.0%
research growing therapy market
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.18%
H: 0.12%
C: -0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.